Skip to main content
SpringerLink
Log in

Expression of p53 protein in pancreatic adenocarcinoma

Relationship to cigaret smoking

  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

We studied the expression of p53 gene product in pancreatic adenocarcinomas of the usual ductal type to determine its relationship to cigaret smoking and its usefulness as an independent prognostic indicator. Twenty-six resection speciments of pancreatic adenocarcinoma were examined by immunohistochemistry using an antigen retrieval solution and monoclonal PAb 1801 and polyclonal CM1 antibodies on paraffin-embedded material. Specific nuclear p53 expression for both PAb1801 and CM1 was identified in seven cases (27%). In all cases immunoreaction was confined to neoplastic cells. Three of four (75%) tumors from patients who had never smoked showed immunoreaction, whereas only three of 14 (21%) tumors from smokers showed positive staining. Cases with positive staining had shorter mean survival (6.3 mo) than cases that failed to stain (9.8 mo), but the difference was not statistically significant in this small study. There was no statistically significant association between p53 immunoreactivity and other clinicopathologic parameters. Our findings indicate that abnormalities of p53 gene in pancreatic adenocarcinomas may not be directly related to cigaret smoking. Those patients who survived the longest tended to have tumors negative for p53 immunostaining. p53 immunoreaction may be a useful feature in distinguishing adenocarcinoma from chronic pancreatitis in small biopsies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma.N Engl J Med 1992; 326: 455–465.

    Article  PubMed  CAS  Google Scholar 

  2. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.Cell 1988; 53: 549–554.

    Article  PubMed  CAS  Google Scholar 

  3. Grunewald K, Lyons J, Frohlich A, Fleichtinger H, Weger RA, Schwab G, Janssen JWG, Bartram CR. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas.Int J Cancer 1989; 43: 1037–1041.

    Article  PubMed  CAS  Google Scholar 

  4. Hruban RH, van Mansfeld ADM, Offerhaus GJA, van Weering DHJ, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL. K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol 1993; 143: 545–554.

    PubMed  CAS  Google Scholar 

  5. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Kloppel G, Theis B, Russell RCG, Neoptolemos J, Williamson RCN, Lane DP, Lemoine NR. Abnormalities of the p53 suppressor gene in human pancreatic cancer.Br J Cancer 1991; 64: 1076–1082.

    PubMed  CAS  Google Scholar 

  6. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, Hirohashi S. Pancreatic adenocarcinomas frequently show p53 gene mutations.Am J Pathol 142: 1534–1543.

  7. Casey G, Yamanaka Y, Friess H, Kobrin MS, Lopez ME, Buchler M, Beger HG, Korc M. p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis.Cancer Letters 1993; 69: 151–160.

    Article  PubMed  CAS  Google Scholar 

  8. DiGiuseppe JA, Hruban RH, Goodman SN, Polak M, van der Berg FM, Allison DC, Cameron JL, Offerhaus GJA. Overexpression of the p53 tumor suppressor protein in pancreatic adenocarcinoma.Mod Pathol 1993; 6: 109A Abstract.

    Google Scholar 

  9. Zhang SY, Ruggeri B, Agarwal P, Sorling AF, Obara T, Ura H, Namiki M, Klein-Szanto AJP. Immunohistochemical analysis of p53 expression in human pancreatic carcinomas.Arch Pathol Lab Med 1994; 118: 150–154.

    PubMed  CAS  Google Scholar 

  10. Boschman C, Reddy JK, Rao MS. Immunohistochemical analysis of p53 protein expression in human pancreatic ductal adenocarcinomas and precursor lesions.Mod Pathol 1994; 7: 129A Abstract.

    Google Scholar 

  11. Hameed M, Marrero AM, Conlon KC, Brennan MF, Klimstra DS. Expression of p53 nucleophosphoprotein in in situ pancreatic ductal adenocarcinoma: an immmunohistochemical analysis of 100 cases.Mod Pathol 1994; 7: 132A Abstract.

    Google Scholar 

  12. Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE. High prevalence of p53 mutations, particularly intragenic microdeletions, in resectable pancreatic carcinoma.Gastroenterology 1994; 106: A459 Abstract.

    Google Scholar 

  13. Rall CJN, Graeme-Cooke F, Beauchamp R, Yandell DW, Rustgi AK. p53 tumor suppressor gene mutations and protein overexpression in pancreatic ductal adenocarcinomas.Gastroenterology 1994; 106: A460 Abstract.

    Google Scholar 

  14. Westra WH, Offerhaus GJA, Goodman SN, Polak M, Baas IO, Hruban RH. Overexpression of the p53 tumor suppressor protein in primary lung adenocarcinomas is associated with cigarette smoking.Mod Pathol 1993; 6: 135A Abstract.

    Google Scholar 

  15. Ensley JF, Maciorowski Z, Pietraszkiewicz H, Klemic G, Kukuruga M, Sapareto S, Corbett T, Crissman J. Solid tumor preparation for flow cytometry using a standard murine model.Cytometry 1987; 8: 479–487.

    Article  PubMed  CAS  Google Scholar 

  16. Marx J. Research news: many gene changes found in cancer.Science 1989; 246: 1386–1388.

    Article  PubMed  CAS  Google Scholar 

  17. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene.Nature 1991; 351: 453–456.

    Article  PubMed  CAS  Google Scholar 

  18. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers.Science 1991; 253: 49–53.

    Article  PubMed  CAS  Google Scholar 

  19. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use.N Engl J Med 1994; 330: 907–912.

    Article  PubMed  CAS  Google Scholar 

  20. Carbone DP. Oncogenes and tumor suppressor genes.Hosp Pract 1993; 28: 145–161.

    CAS  Google Scholar 

  21. Montague DC, Lyn-Cook BD, Chang L, Rayford PL, Chowdhury P. Exposure to nicotine induces H-ras mutations in rat pancreatic acinar cells.Gastroenterology 1994; 106: A463 Abstract.

    Google Scholar 

  22. Boring CC, Squires TS, Tong T.Cancer Statistics 1991. CA 1991; 41: 19–36.

    CAS  Google Scholar 

  23. Gastrointestinal tumor study group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer.Cancer 1987; 59: 2006–2010.

    Article  Google Scholar 

  24. Gastrointestinal tumor study group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone.J Natl Cancer Inst 1988; 80: 751–755.

    Article  Google Scholar 

  25. Poller DN, Roberts EC, Bell JA, Elston CW, Blamey RW, Ellis IO. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein.Hum Pathol 1993; 24: 463–468.

    Article  PubMed  CAS  Google Scholar 

  26. Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR. Immunohistochemical detection of p53 protein in mammary carcinoma: an important new independent indicator of prognosis?Hum Pathol 1993; 24: 469–476.

    Article  PubMed  CAS  Google Scholar 

  27. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, Nordenskjold B. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.Lancet 1992; 340: 1369–1373.

    Article  PubMed  CAS  Google Scholar 

  28. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ, Thomas G. Association of p53 mutations with short survival in colorectal cancer.Gastroenterology 1994; 106: 42–48.

    PubMed  CAS  Google Scholar 

  29. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer.Cancer Res 1992; 52: 4828–4831.

    PubMed  CAS  Google Scholar 

  30. Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F. p53 expression and prognosis in gastric carcinoma.Int J Cancer 1992; 50: 859–862.

    Article  PubMed  CAS  Google Scholar 

  31. Volkholz H, Stolte M, Becker V. Epithelial dysplasias in chronic pancreatitis.Virchows Arch (Pathol Anat) 1982; 396: 331–349.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, College of Medicine, University of Kentucky, 40536-0093, Lexington, KY

    Eun Y. Lee, Michael L. Cibull, Evelyn O'Daniel-Pierce, William E. Strodel & C. Darrell Jennings

Authors
  1. Eun Y. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael L. Cibull
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Evelyn O'Daniel-Pierce
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William E. Strodel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Darrell Jennings
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, E.Y., Cibull, M.L., O'Daniel-Pierce, E. et al. Expression of p53 protein in pancreatic adenocarcinoma. Int J Pancreatol 17, 237–242 (1995). https://doi.org/10.1007/BF02785820

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02785820

Key Words

Search

Navigation